Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SWK | Common Stock | Sale | -$424K | -5.25K | -22.58% | $80.80 | 18K | Nov 10, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | SWK | Stock Option (Right to Buy) | 2.5K | Nov 10, 2022 | Common Stock | 2.5K | $130.88 | Direct | F2 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.7600 to $80.8300. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. |
F2 | The Form 3 filed by the reporting person on July 7, 2022 overstated the remaining number of stock options held by the reporting person related to a grant of stock options that began vesting as of December 4, 2019. This Form 4 reflects the correct number of such remaining stock options held by the reporting person as 2,500. This grant of stock options began vesting in four equal annual installments on December 4, 2019, with the remaining 2,500 stock options becoming exercisable as of December 4, 2022. |